Celyad Oncology’s $25 Million At The Market Offering

CMS Belgium, together with Harvest Law, assisted Celyad Oncology on the deal. Celyad Oncology, a Belgian biotech company listed on Euronext Brussels/Paris and on the Nasdaq…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here